Trial Profile
A research study for patients with overactive bladder
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- Sponsors Allergan
- 01 Aug 2012 New source identified and integrated (German Clinical Trials Register; DRKS00004022).
- 01 Aug 2012 Additional trial locations identified as reported by German Clinical Trials Register.
- 01 Aug 2012 Planned number of patients changed from 270 to 313 as reported by German Clinical Trials Register.